Topic: Affective Disorders (Bipolar)

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	S-02 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Affective Disorders (Bipolar)
Track:	1 Basic
Session title:	Comparative neuropathology of schizophrenia and bipolar disorder
	Bernhard Bogerts, Germany	Chair
	Sabine Bahn, United Kingdom	Co-Chair

001	Peripheral biomarkers as indicators of brain pathology in schizophrenia and affective disorder
	Sabine Bahn, United Kingdom	Speaker
002	White matter abnormalities in schizophrenia and bipolar disorder
	Andrew Dwork, USA	Speaker
003	Immunohistochemical studies in schizophrenia and bipolar disorder
	Bernhard Bogerts, Germany	Speaker
004	Ultrastructural studies in schizophrenia and bipolar disorder
	Natalia Uranova, Russia	Speaker

No.	S-11 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Affective Disorders (Bipolar)
Track:	1 Basic
Session title:	Vigilance regulation in affective disorders
	Ulrich Hegerl, Germany	Chair
	Nathalie Besnier, France	Co-Chair

001	Is mania an autoregulatory attempt to stabilize vigilance and are psychostimulants a treatment option?
	Peter Schönknecht, Germany	Speaker
002	Excessive daytime sleepiness: The role of anxiety, insomnia and depression
	Gregor Hasler, Switzerland	Speaker
003	Vigilance and cognition in bipolar affective disorders
	Nathalie Besnier, France	Speaker
004	Sleep disturbances in patients with affective disorders
	Goeran Hajak, Germany	Speaker

No.	S-22 - Symposium
Time:	16.00-17.30
Room:	Room 352AB
Topic:	Affective Disorders (Bipolar)
Track:	2 Clinical
Session title:	Suicide prevention: Focusing on modifiable risk factors
	Zoltan Rihmer, Hungary	Chair
	Hagop S. Akiskal, USA	Co-Chair

001	Prophylaxis of bipolar disorder
	Leonardo Tondo, USA	Speaker
002	Treatment of depression
	Zoltan Rihmer, Hungary	Speaker
003	Are sudden dips in mood the final common pathway of suicide?
	Hagop S. Akiskal, USA	Speaker
004	Are any of the biological substrates of suicidality modifiable?
	Leo Sher, USA	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	FC-11 - Free Communications
Time:	12.30-14.00
Room:	Room 242A
Topic:	Affective Disorders (Bipolar)
Session title:	Affective Disorders (Bipolar)
	Frank Bellivier, France	Chair
	Francesc Colum, Spain	Co-Chair

001	How often bipolar disorder merges after a diagnosis of unipolar depression?
	Ruby Castilla-Puentes, USA	Speaker
002	Women with bipolar disorder: Clinical challenges
	Ruth Baruch, Canada	Speaker
003	Do psychotic symptoms in mania predict later course of bipolar disorder?
	Diego Novick, United Kingdom	Speaker
004	Cognitive Behavior Therapy (CBT) versus Psychoeducation (PE) in bipolar disorder: A randomized controlled study
	Gerhard Lenz, Austria	Speaker
005	Cross-prevalence of migraine and bipolar disorder
	Abigail Ortiz-Dominguez, Canada	Speaker
006	Cognitive emotion regulation and inhibitory mechanisms in bipolar disorder and schizophrenia
	Melissa Green, Australia	Speaker

No.	P-13 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Affective Disorders (Bipolar)
Session title:	Affective Disorders (Bipolar) I
	Heinz Grunze, United Kingdom	Chair

001	Validity of the “National Institutes of Mental Health Life Chart – self version” (NIHM-sLCM)
	Christoph Born, Germany	Presenter
002	Lamotrigine in the treatment of bipolar disorder in women of reproductive age
	Natalie Rasgon, USA	Presenter
003	Differences in clinical features between bipolar I and II disorders
	Ji-Hyun Baek, Korea, Republic of	Presenter
004	Subsyndromical symptoms as manifestation of alarm in the patients with bipolar disorder
	Desiree Harnic, Italy	Presenter
005	Late onset bipolar disorder differential characteristics
	Miguel Vega Pineiro, Spain	Presenter
006	Subclinical anxiety as an endophenotypic marker in Costa Rican bipolar I patients
	Javier Contreras, Costa Rica	Presenter
007	Bipolar disorder in patients with a current diagnosis of major depressive episode
	Jean-Michel Azorin, France	Presenter
008	A naturalistic study of olanzapine in the treatment of patients with manic or mixed episodes of bipolar disorder: Results from 12-weeks acute phase treatment with olanzapine in monotherapy and in combination
	Pavel Vohlidka, United Kingdom	Presenter
009	Neurological comorbidities in patients with bipolar disorder: A systematic review
	Julio Bobes, Spain	Presenter
010	Spatial working memory function in bipolar disorder and schizophrenia
	Marcela Barguil, USA	Presenter
011	Illness experience and reasons for non-adherence among individuals with bipolar disorder who are poorly adherent with medication
	Martha Sajatovic, USA	Presenter
012	Depressive symptom ratings in geriatric patients with type I bipolar mania
	Martha Sajatovic, USA	Presenter
013	Mood disorders associated with interferon treatment: Development and validation of a mood disorders diagnostic screening questionnaire: The DETHEC questionnaire
	Martin Patrick, France	Presenter
014	Impact of psychoeducation in bipolar disorder on the quality of life
	Radhouene Kachouri, Tunisia	Presenter
015	Monotherapy with olanzapine of acute manic episode
	Christos Istikoglou, Greece	Presenter
016	ADHD and bipolar disorder: Prevalence of misdiagnosis?
	Juan Carlos Navarro Barrios, Spain	Presenter
017	Total agenesis of the corpus aallosum in a patient with a polymorphic clinical presentation
	Sandra Almeida, Portugal	Presenter
018	Lamotrigine associated rash in adult patients with bipolar i disorder: A multicenter, prospective, naturalistic, open-label trial
	Won-Myong Bahk, Korea, Republic of	Presenter
019	The efficacy of quetiapine in patients with bipolar depression: A multi-center, prospective, open-label, observational study(queen study)
	Won-Myong Bahk, Korea, Republic of	Presenter
020	Body Mass Index (BMI) correlates of bipolar disorder: Can BMI help predict prognosis and outcome?
	Cynthia Calkin, Canada	Presenter

No.	S-39 - Symposium
Time:	16.00-17.30
Room:	Room 352AB
Topic:	Affective Disorders (Bipolar)
Track:	1 Basic
Session title:	Genetic and environmental risk factors in early onset bipolar affective disorder
	Frank Bellivier, France	Chair
	Sven Cichon, Germany	Co-Chair

001	Whole genome association studies in bipolar I affective disorder
	Sven Cichon, Germany	Speaker
002	Candidate gene analyses in early onset bipolar affective disorder
	Bruno Etain, France	Speaker
003	Whole genome association analyses in early onset bipolar disorder
	Stephane Jamain, France	Speaker
004	Gene-environment interactions in early onset bipolar disorder
	Frank Bellivier, France	Speaker

« previous day	Tuesday, 30. June 2009	next day »

No.	S-44 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Affective Disorders (Bipolar)
Track:	3 Interface
Session title:	60 years of lithium in neuropsychiatry - recent discoveries in basic and clinical research
	Michael Bauer, Germany	Chair
	Janusz Rybakowski, Poland	Co-Chair

001	Response to long-term lithium treatment and its use as an endophenotype for bipolar disorder
	Martin Alda, Canada	Speaker
002	Neuroprotective properties of lithium
	Robert Belmaker, Israel	Speaker
003	Genome-wide findings from the Consortium on Lithium Genetics (ConLiGen)
	Thomas G. Schulze, USA	Speaker
004	Lithium at work: The neurobiologist's perspective -from animal models to the development of novel therapeutics
	Husseini Manji, USA	Speaker

No.	TG-05 - WFSBP Treatment Guidelines
Time:	11.00-12.30
Room:	Room 242A
Topic:	Affective Disorders (Bipolar)
Session title:	Bipolar disorders
	Guy Goodwin, United Kingdom	Chair

	Eduard Vieta, Spain	Presenter
	Heinz Grunze, United Kingdom	Presenter

No.	P-22 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Affective Disorders (Bipolar)
Session title:	Affective Disorders (Bipolar/Unipolar)
	Jose Luis Ayuso Gutierrez, Spain	Chair

001	Social perception and emotion regulation in bipolar disorder and schizophrenia
	Melissa Green, Australia	Presenter
002	The prevalence of metabolic syndrome in Tunisian patients with bipolar I disorder
	Asma Ezzaher, Tunisia	Presenter
003	Vagus nerve stimulation in treatment-resistant depression: An Italian case-series
	Bernardo Dell’Osso, Italy	Presenter
004	Gender differences in relation to comorbidity patterns and abuse in bipolar disorder
	Bernardo Dell’Osso, Italy	Presenter
005	Eating disorder and bipolar disorder: A hard to treat comorbidity
	Diogo Guerreiro, Portugal	Presenter
006	Risk of cancer and HIV infection in patients with bipolar disorder: A systematic review
	Julio Bobes, Spain	Presenter
007	Treatment with escitalopram of patients with depressive disorders admitted in a general hospital
	Jose Luis Rodriguez, Spain	Presenter
008	Prevalence of mixed episode in Korean bipolar patients
	Kyung-Joon Min, Korea, Republic of	Presenter
009	Neural oscillatory activity to speech sounds in bipolar disorder
	Naoya Oribe, Japan	Presenter
010	Affective disorders as risk factors for delirium after cardiac surgery
	Phillip J. Tully, Australia	Presenter
011	Columbia University Lithium Archives Project: Bridging the gap from laboratory evidence to clinical findings
	Ronald Fieve, USA	Presenter
012	Bipolar Disorders (BPD) in Emergency Departments (ED) in Latin-America: Prevalence and associated comorbidity
	Ruby Castilla-Puentes, USA	Presenter
013	Chronic musculoskeletal pain: Depression, anxiety and altered cytokine levels
	Saskia Hahnenkamp, Germany	Presenter
014	Effect of Melatonin on the serotonergic neural activity across the light-dark cycle
	Sergio Dominguez Lopez, Canada	Presenter
015	Lithium effects on the chronobiological model of affective disorder
	Tatyana Zamoshchina, Russia	Presenter
016	The Redundant Signal Effect as index of abnormal interhemispheric integration in schizophrenic and bipolar patients
	Vincenzo Florio, Italy	Presenter
017	Auditory sensory gating deficit to voices in patients with psychotic bipolar disorder: A MEG study
	Yoji Hirano, Japan	Presenter
018	Depression and coagulation of blood
	Elena Mikhaylova, Russia	Presenter
019	Headache and personal disorders in local wars participants
	Elena Mikhaylova, Russia	Presenter

« previous day	Wednesday, 1. July 2009	next day »

No.	S-63 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Affective Disorders (Bipolar)
Track:	2 Clinical
Session title:	How far are we from reducing suicide in bipolar disorder?
	Frank Bellivier, France	Chair
	Eduard Vieta, Spain	Co-Chair

001	Suicidal risk in BP patients and bipolar risk in suicidal patients?
	Philippe Courtet, France	Speaker
002	Gene-environment interaction and the risk of suicidal behavior in bipolar patients
	Bruno Etain, France	Speaker
003	Psychosocial interventions in bipolar disorder: Impact on morbidity and mortality
	Francesc Colum, Spain	Speaker
004	Suicide prevention in bipolar patients
	Guy Goodwin, United Kingdom	Speaker

« previous day	Thursday, 2. July 2009

No.	FC-34 - Free Communications
Time:	12.30-14.00
Room:	Room 351
Topic:	Affective Disorders (Bipolar)
Session title:	Affective Disorders (Bipolar/Unipolar)
	Janusz Rybakowski, Poland	Chair
	Jose Luis Ayuso Gutierrez, Spain	Co-Chair

001	State-dependent elevation of interleukin-1 receptor antagonist (IL-1Ra) in bipolar mania
	Shang-Ying Tsai, Taiwan	Speaker
002	The use of background EEG activity to determine stimulus timing as a means of improving rTMS efficacy in the treatment of depression: A controlled comparison with standard techniques
	Joseph Lee, Australia	Speaker
003	Dopamine-beta-hydroxylase localization and outer membrane disruption of spherical acidophilic inclusions in depression
	Marietta R. Issidorides, Greece	Speaker
004	DNA methylation profiling of major depression
	Fatemeh Haghighi, USA	Speaker
005	Serotonin Transporter gene polymorphims and it correlation with depressive patients
	Patricia Chieri, Argentina	Speaker
006	Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder
	Jared Van Snellenberg, USA	Speaker

No.	P-42 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Affective Disorders (Bipolar)
Session title:	Affective Disorders (Bipolar) II
	Rainer Wolf, Germany	Chair

001	Factors associated with spatial working memory function in euthymic bipolar patients
	Aleksandra Suwalska, Poland	Presenter
002	Serum Progesterone in males during euthymic phase of Bipolar Disorder - subtype differences
	Anette Johansson, Sweden	Presenter
003	Quetiapine in the treatment of bipolar depression: Improvements in quality of life and functioning in four randomized, placebo - controlled trials
	Urban Gustafsson, Sweden	Presenter
004	The efficacy of quetiapine monotherapy in bipolar depression: Combined data from the BOLDER and EMBOLDEN studies
	Urban Gustafsson, Sweden	Presenter
005	The efficacy of quetiapine monotherapy in bipolar II depression: Combined data from the BOLDER and EMBOLDEN studies
	Urban Gustafsson, Sweden	Presenter
006	Effect of Quetiapine on the subjective estimates of sleep in the 8 weeks treatment of acute bipolar depression
	Bo-Hyun Yoon, Korea, Republic of	Presenter
007	Preclinical characterization of antidepressant effect of norquetiapine: Role of the norepinephrine transporter in preclinical depression models
	Dan Widzowski, USA	Presenter
008	Association study of brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in Korea
	Duk-In Jon, Korea, Republic of	Presenter
009	Nutritional, metabolic and endocrine disorders in patients with bipolar disorder: A systematic review
	Julio Bobes, Spain	Presenter
010	The clinical approach to bipolar disorder diagnosis
	Giuseppe Tavormina, Italy	Presenter
012	French validation of the BAC-A (brief assessment of cognition in affective disorders): A pilot study
	Marie-Cecile Bralet, France	Presenter
013	Bipolarity in adolescent populations
	Nicolas Zdanowicz, Belgium	Presenter
014	Asenapine efficacy in patient subpopulations experiencing manic or mixed episodes of bipolar disorder: A pooled analysis
	Roger S. McIntyre, Canada	Presenter
015	A study to evaluate the efficacy, safety and tolerability of atipical antipcychotics in subjects with bipolar disorder Type 1
	Roxana Chirita, Romania	Presenter
016	Cannabis use and bipolar disorder: Search for association and causality through a review of literature
	Sami Richa, Lebanon	Presenter
017	Family history, obstetric complications and age of onset in bipolar patients
	Selim El-Badri, New Zealand	Presenter
018	Mixed states with or without psychotic symptoms: 24-month outcomes of the European Cohort Emblem
	Michael Lukasiewicz, France	Presenter
019	Spanish consensus on physical health in patients with bipolar disorder
	Eduard Vieta, Spain	Presenter

No.	S-87 - Symposium
Time:	14.00-15.30
Room:	Salle Maillot
Topic:	Affective Disorders (Bipolar)
Track:	3 Interface
Session title:	Clinical and biological correlates of outcome prediction in major psychoses
	Carlo Altamura, Italy	Chair
	Trevor Young, Canada	Co-Chair

001	Bipolar disorder
	Trevor Young, Canada	Speaker
002	Neuromorphology and outcome prediction
	Philip McGuire, France	Speaker
003	Psychoimmunology and drug response
	Norbert Müller, Germany	Speaker
004	Duration of untreated psychosis: is it a criterion for outcome prediction?
	Carlo Altamura, Italy	Speaker

« Back

---